507 related articles for article (PubMed ID: 28095558)
21. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
22. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a prescription strength 4% hydroquinone/10% L-ascorbic acid treatment system for normal to oily skin.
Bruce S; Watson J
J Drugs Dermatol; 2011 Dec; 10(12):1455-61. PubMed ID: 22134571
[TBL] [Abstract][Full Text] [Related]
24. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
26. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation.
Goberdhan L; Schneider K; Makino ET; Bautista A; Mehta RC
J Cosmet Dermatol; 2024 May; 23(5):1726-1733. PubMed ID: 38288515
[TBL] [Abstract][Full Text] [Related]
29. Open-Label Study Evaluating the Anti-Aging Effects of a 3-Product, 2-Step Retinol-Rejuvenation System Following 3 Months of Treatment in Subjects With Photodamage.
Bruce S; Barkovic S
J Drugs Dermatol; 2017 Jan; 16(1):23-28. PubMed ID: 28095529
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, split-face study comparing the efficacy and tolerability of three retinol-based products vs. three tretinoin-based products in subjects with moderate to severe facial photodamage.
Babcock M; Mehta RC; Makino ET
J Drugs Dermatol; 2015 Jan; 14(1):24-30. PubMed ID: 25607905
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%.
Ho ET; Trookman NS; Sperber BR; Rizer RL; Spindler R; Sonti S; Gotz V; Mehta R
J Drugs Dermatol; 2012 Jan; 11(1):64-9. PubMed ID: 22206079
[TBL] [Abstract][Full Text] [Related]
32. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A
J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of a 1550nm/1927nm Dual Wavelength Laser for the Treatment of Photodamaged Skin.
Narurkar VA; Alster TS; Bernstein EF; Lin TJ; Loncaric A
J Drugs Dermatol; 2018 Jan; 17(1):41-46. PubMed ID: 29320586
[TBL] [Abstract][Full Text] [Related]
35. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Facial Photodamage With Mass Market Topical Products vs Non-ablative Fractional Laser.
Reich H; Wallander I; Schulte L; Goodier M; Zelickson B
J Drugs Dermatol; 2016 Nov; 15(11):1366-1372. PubMed ID: 28095549
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
39. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
[TBL] [Abstract][Full Text] [Related]
40. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
Pratchyapurit WO
J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
